192 related articles for article (PubMed ID: 12522088)
21. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
[TBL] [Abstract][Full Text] [Related]
22. Muscarinic inhibition of quantal transmitter release from the magnesium-paralysed frog sartorius muscle.
Arenson MS
Neuroscience; 1989; 30(3):827-36. PubMed ID: 2788830
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies to fetal bovine serum acetylcholinesterase distinguish between acetylcholinesterases from ruminant and non-ruminant species.
Naik RS; Belinskaya T; Vinayaka CR; Saxena A
Chem Biol Interact; 2020 Oct; 330():109225. PubMed ID: 32795450
[TBL] [Abstract][Full Text] [Related]
24. Influence of differential expression of acetylcholinesterase in brain and muscle on respiration.
Boudinot E; Bernard V; Camp S; Taylor P; Champagnat J; Krejci E; Foutz AS
Respir Physiol Neurobiol; 2009 Jan; 165(1):40-8. PubMed ID: 18977317
[TBL] [Abstract][Full Text] [Related]
25. Release and synthesis of acetylcholine at ectopic neuromuscular junctions in the rat.
van Kempen GT; Molenaar PC; Slater CR
J Physiol; 1994 Jul; 478 ( Pt 2)(Pt 2):229-38. PubMed ID: 7965844
[TBL] [Abstract][Full Text] [Related]
26. Structural and functional characterization of an organometallic ruthenium complex as a potential myorelaxant drug.
Trobec T; Žužek MC; Sepčić K; Kladnik J; Kljun J; Turel I; Benoit E; Frangež R
Biomed Pharmacother; 2020 Jul; 127():110161. PubMed ID: 32380389
[TBL] [Abstract][Full Text] [Related]
27. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
Bosak A; Gazić I; Vinković V; Kovarik Z
Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
[TBL] [Abstract][Full Text] [Related]
28. Ryanodine facilitates calcium-dependent release of transmitter at mouse neuromuscular junctions.
Nishimura M; Tsubaki K; Yagasaki O; Ito K
Br J Pharmacol; 1990 May; 100(1):114-8. PubMed ID: 1973623
[TBL] [Abstract][Full Text] [Related]
29. Remodeling of the neuromuscular junction in mice with deleted exons 5 and 6 of acetylcholinesterase.
Girard E; Bernard V; Camp S; Taylor P; Krejci E; Molgó J
J Mol Neurosci; 2006; 30(1-2):99-100. PubMed ID: 17192646
[TBL] [Abstract][Full Text] [Related]
30. Acetylcholinesterase deficiency contributes to neuromuscular junction dysfunction in type 1 diabetic neuropathy.
Garcia CC; Potian JG; Hognason K; Thyagarajan B; Sultatos LG; Souayah N; Routh VH; McArdle JJ
Am J Physiol Endocrinol Metab; 2012 Aug; 303(4):E551-61. PubMed ID: 22739110
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin and 4-aminoquinoline induce a similar abnormal type of spontaneous quantal transmitter release at the rat neuromuscular junction.
Thesleff S; Molgó J; Lundh H
Brain Res; 1983 Mar; 264(1):89-97. PubMed ID: 6133583
[TBL] [Abstract][Full Text] [Related]
32. The effect of a reduction in temperature on the quantal release of transmitter at the mouse neuromuscular junction.
Nishimura M; Shimizu Y; Satoh E; Yokoyama T; Yagasaki O
Gen Pharmacol; 1993 Sep; 24(5):1235-9. PubMed ID: 7903651
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
Wu J; Pistolozzi M; Liu S; Tan W
Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
[TBL] [Abstract][Full Text] [Related]
34. Glycolytic type I white muscle fibres lack butyrylcholinesterase activity at acetylcholinergic end plates.
Khan MA
Cytobios; 1979; 26(103-104):167-73. PubMed ID: 552306
[TBL] [Abstract][Full Text] [Related]
35. Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
McArdle JJ; Sellin LC; Coakley KM; Potian JG; Quinones-Lopez MC; Rosenfeld CA; Sultatos LG; Hognason K
Neuropharmacology; 2005 Dec; 49(8):1132-9. PubMed ID: 16081111
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
[TBL] [Abstract][Full Text] [Related]
37. Role of acetylcholinesterase on the structure and function of cholinergic synapses: insights gained from studies on knockout mice.
Adler M; Sweeney RE; Hamilton TA; Lockridge O; Duysen EG; Purcell AL; Deshpande SS
Cell Mol Neurobiol; 2011 Aug; 31(6):909-20. PubMed ID: 21538119
[TBL] [Abstract][Full Text] [Related]
38. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
39. Butyrylcholinesterase in guinea pig lung lavage: a novel biomarker to assess lung injury following inhalation exposure to nerve agent VX.
Graham JR; Wright BS; Rezk PE; Gordon RK; Sciuto AM; Nambiar MP
Inhal Toxicol; 2006 Jun; 18(7):493-500. PubMed ID: 16603480
[TBL] [Abstract][Full Text] [Related]
40. Desensitization shortens the high-quantal-content endplate current time course in frog muscle with intact cholinesterase.
Giniatullin RA; Talantova M; Vyskocil F
J Physiol; 1997 Aug; 502 ( Pt 3)(Pt 3):641-8. PubMed ID: 9279814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
